The SEER Program continues to evolve to meet the changing landscape of cancer research and public health. Future directions include:
Expanding data collection to include new cancer types and emerging risk factors. Incorporating genomic data and other molecular markers to enhance understanding of cancer biology and personalized medicine. Leveraging big data analytics and machine learning to uncover new insights from the vast amount of information collected. Enhancing collaborations with other national and international cancer registries to improve data comparability and global cancer surveillance.
